Harrow Statistics
NASDAQ: HROWHealth CareBiotechnology: Pharmaceutical PreparationsUSD
30.62+0.27 (+0.89%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Harrow by the numbers
Harrow has a market capitalization of $1.15 billion based on 37.49M shares outstanding. With trailing EPS of $-0.98, Harrow is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 16.8% below its 50-day average and 23.9% below its 200-day average.
Average daily trading volume is 552.42K shares, or about $16.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
HROW valuation vs. peer median
| Metric | HROW | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.15B | $1.09B | +5% |
| Avg. volume | 552.42K | 699.31K | -21% |
Peer median across 8 companies: AVLN, MNKD, LBRX, JANX, TRAX, BCAX, AMPH, OPK.
Valuation
- Market cap
- $1.15B
- Forward P/E
- 11.04
- EPS (TTM)
- $-0.98
- Shares outstanding
- 37.49M
Price and trading
- Previous close
- 30.35
- Open
- 30.09
- Day range
- 29.90 – 31.11
- 52-week range
- 28.54 – 54.85
- 52-week change
- -26.92%
- Beta
- —
- Volume
- 707.62K
- Average volume
- 552.42K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 10, 2026
Additional statistics
- Market Cap
- 1.15B
- Forward Pe
- 11.04
- Eps
- -0.98
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 54.85
- Week52 Low
- 28.54
- Avg Volume
- 552.42K
- Shares Outstanding
- 37.49M
- Ma50
- 36.82
- Ma200
- 40.21
- Earnings Date
- Aug 10, 2026
- Pct From52w High
- -44.18%
- Pct From52w Low
- 7.29%